You are currently viewing the summary.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Summary
Health experts hail two new Chinese-made vaccines against hand, foot, and mouth disease as a milestone against a malady that has run rampant in China. But that triumph was overshadowed by a safety crisis involving other homegrown vaccines. In recent weeks, police have arrested more than 200 people in connection with the nationwide distribution of 2 million doses of expired Chinese-made vaccines against scourges such as hepatitis B and rabies. No adverse reactions have been confirmed. China's vaccine developers hope the debacle won't derail efforts to make inroads into the global $33 billion vaccine market. But without a major overhaul, China's vaccine system might not recover quickly.
↵* in Beijing
